OTC: NURPF - Neuren Pharmaceuticals Limited

Yield per half year: -44.79%
Dividend yield: 0.00%
Sector: Healthcare

Reporting Neuren Pharmaceuticals Limited

Capitalization

IFRS
Reporting Annual Quarterly
2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 LTM 5 year average CAGR 5
Капитализация, млрд $
0.1955 0.2434 0.1681 0.1206 0.1216 0.1702 0.4408 1.07
Выручка, млрд $
0.0024 0.0012 0.0001 0.0135 0.000495 0.000717 0.0032 0.0146 0.2319 0.2319
Чистая прибыль, млрд $
-0.0134 -0.012 -0.0018 0.0031 -0.0108 -0.0092 -0.0078 0.000184 0.1571 0.1571
EV, млрд $
0.0822 0.1483 0.0715 0.268 0.9298 2.92 2.93
EBIT, млрд $
-0.0173 -0.0152 -0.0063 0.0053 -0.0116 -0.0095 -0.0114 -0.0016 0.1992 0.1992
EBITDA, млрд $
-0.0173 -0.0152 -0.0062 0.0054 -0.0116 -0.0095 -0.0114 -0.0016 0.1992 0.1992
Баланс стоимость, млрд $
0.0144 0.0042 0.0164 0.0247 0.0138 0.0242 0.0393 0.0416 0.2052 0.2052
FCF, млрд $
-0.0127 -0.0124 -0.0056 0.0064 -0.0117 -0.0081 -0.01 0.0036 0.1849 0.1849
Операционный денежный поток, млрд $
-0.0127 -0.0124 -0.0056 0.0064 -0.0117 -0.0081 -0.01 0.0036 0.1849 0.1849
Операционная прибыль, млрд $
-0.0173 -0.0152 -0.0063 0.0053 -0.0116 -0.0095 -0.0114 -0.0016 0.1725 0.1992
Операционные расходы, млрд $
0.0173 0.0152 0.0063 0.0083 0.0116 0.0095 0.0114 0.0162 0.0327 0.0327
CAPEX, млрд $
0 0.0000 0.0000 0.0000 0.0000 0 0.0000 0.0000 0.0000 0.0000


Balance sheet

IFRS
Reporting Annual Quarterly
2004 2006 2007 2008 2009 2010 2011 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 LTM 5 year average CAGR 5
Наличность, млрд $
0.0166 0.0051 0.0047 0.0236 0.0138 0.0242 0.0368 0.0402 0.0171 0.0171
Short Term Investments $
0.0091 0.2114 0.2114
Long term investments $
0.0014
Total Receivables $
0.0000 0.0000 0.0001 0.000942 0.000552 0.000755 0.0014 0.0011 0.0144 0.0144
Total Current Assets $
0.0167 0.0061 0.0161 0.0266 0.0144 0.0249 0.04 0.0432 0.2472 0.2472
Чистые активы, млрд $
0.0000 0.0000 0 0.0000 0 0 0.0000 0.0000 0.0000 0.0000
Активы, млрд $
0.0169 0.0062 0.0179 0.0266 0.0144 0.025 0.0401 0.0433 0.248 0.248
Short Term Debt $
0.0000 0.0035 0.0000 0 0.000454
Задолженность, млрд $
0.0025 0.002 0.0016 0.002 0.000559 0.000753 0.000803 0.0017 0.0428 0.0428
Чистый долг, млрд $
-0.0166 -0.0051 -0.0047 -0.0236 -0.0138 -0.0242 -0.0368 -0.0402 -0.0171 -0.0171
Interest income $
0.000188 0.0000 0.000218 0.000389 0.000147 0.0000 0.000391 0.0057
Расходы на обслуживание долга $
0.0001 0.0000 0 0 0
Чист. проц. доходы, млрд $
0.000188 0.0000 0.000218 0.000389 0.000147 0.0000 0.000391 0.0057 0.0039
Амортизация, млрд $
0.0001 0.0001 0.0001 0.0001 0 0 0 0.0000 0.0000 0.0000
Себестоимость, млрд $
0.0103 0.000947 0.000707 0.000373 0 0 0 0.0000 0.0268 0.0268
Товарно материальные запасы $
0.0000 0.0107 -0.000539 -0.000755 0 0.0144


Share

IFRS
Reporting Annual Quarterly
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 LTM 5 year average CAGR 5
EPS -0.125 -0.0893 0.0224 0.0071 -0.0624 -0.0718 -0.0261 0.0014 1.2 1.2
Цена акции ао 0.772 2.53 1.08 1.71 0.96 2.79 5.45 16.98 7.87 7.87
Число акций ао, млн 149.55 165.79 90.6 102.67 117.61 128.97 128.91 130.77 130.77
FCF/акцию -0.0828 -0.0337 0.0707 -0.1143 -0.0687 -0.0774 0.0278 1.41 1.41


Efficiency

IFRS
Reporting Annual Quarterly
2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 LTM Industry average 5 year average CAGR 5
ROE, % -93.02 -287.21 -11.05 12.46 -78.11 -37.99 -19.86 0.4552 127.3 76.55 18.50
ROA, % -79.25 -193.46 -10.08 11.53 -75.08 -36.84 -19.46 0.4417 107.87 63.35 7.12
ROS, % -2081.5 22.69 -2185.05 -1282.15 -243.79 1.26 67.72 67.73 67.73 67.73 13.40
ROCE, % -120.41 -364.5 -38.35 21.45 -83.59 -39.39 -29.14 -3.86 97.08 97.09 20.78
Рентаб EBITDA, % -522.92 -1416.56 -7134.42 39.64 -2337.58 -1328.59 -357.52 -10.97 85.9 85.91 28.75
Чистая рентаб, % -346.49 -1100.03 -2081.5 22.69 -2185.05 -1282.15 -243.79 1.26 67.72 67.73 13.40
Operation Margin, % -7224.22 39.07 -2338.38 -1329.43 -357.77 -11.04 74.37 85.9 85.9 85.9 19.34
Доходность FCF, % -6.34 -2.3 3.81 -9.72 -6.65 -5.86 0.8121 17.24


Coefficients

IFRS
Reporting Annual Quarterly
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 LTM Industry average 5 year average CAGR 5
P/E
-16.28 -134.61 54.69 -11.15 -13.23 -21.83 5271.65 18.68 18.75 23.38
P/BV
46.74 14.87 6.81 8.71 5.02 4.34 23.32 14.3 14.35 4.29
P/S
2801.85 12.41 243.73 169.58 53.23 66.65 12.65 12.7 3.35
P/FCF
-43.54 26.23 -10.28 -15.04 -17.05 123.13 5.8 0 0 0 11.84
E/P
-0.0074 0.0183 -0.0896 -0.0756 -0.0458 0.000417 0.1465 0 0 0 0.34
EV/EBITDA
23.86 -19.97 -11.7 -36.54 -582.58 14.64 14.7 13.07
EV/Ebit
-19.88 -12.59 -50.68 -578.96 14.64 14.7 14.7 14.7
EV/S
466.76 155.4 130.63 63.89 12.57 12.63 12.63 12.63 3.76
EV/FCF
-19.7 -13.78 -41.84 259.72 15.77 15.84 15.84 15.84 20.52
Debt/EBITDA
0 0 0 0 1.94
Netdebt/Ebitda
0.7594 -4.39 1.2 2.54 3.22 25.18 -0.0858 -0.0858 -0.0858 -0.0858 1.46
Debt/Ratio
0 0 0 0 0.24
Debt/Equity
0 0 0 0 28.57
Debt/Net Income
0 0 0 0 3.20
Бета
4.32 -3.24 -2.55 -2.55 -1.44
Индекс Альтмана
15 8.91 6.38 4.1 3.96 12.45 0.9778 1.67 1.67 1.67 3.53


Dividends

IFRS
Reporting Annual
LTM Industry average 5 year average CAGR 5
Дивиденд
0
Див доход, ао, %
0 2.49


Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription

Subscribe

Other

IFRS
Reporting Annual Quarterly
2019 2020 2021 2022 2023 CAGR 5
ebit_margin
-2338.38 -1228.59 -257.52 -11.04 85.89